Trump Administration’s Planned 25% Tariffs on Pharmaceuticals Expected to Raise U.S. Drug Costs by $51 Billion Annually

Chinese firms report selective exemptions, while Roche seeks relief from U.S. tariffs set to take effect by mid-May under a national security investigation.